IRF8 and cancer: Silenced IRF8 expression in both tumor cells and tumor-induced myeloid cells by DNA methylation and H3K9me3 deposition at the Irf8 promoter are likely major mechanisms underlying OPN elevation in cancer patients and tumor-bearing mice [41,46,47,154,191].